Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| GE Healthcare | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to demonstrate correlation of the H/M ratio of AdreView when derived from a large field of view Anger SPECT system and from a small field of view high sensitivity (CZT) SPECT system.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Adreview LFOV SPECT Imaging followed by SFOV-HE Imaging | Active Comparator | SPECT imaging of 10 millicurie of Adreview |
|
| AdreView SFOV-HE SPECT Imaging followed by LFOV Imaging | Active Comparator | SPECT imaging of 10 millicurie of Adreview |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| AdreView | Drug | 10 millicurie of AdreView (123I-mIBG) |
|
| Measure | Description | Time Frame |
|---|---|---|
| Relationship of H/M ratios obtained on LFOV and SFOV-HE systems | H/M ratios as described will be calculated for the LFOV, and SFOV-HE data sets to determine the correlation between the two measurements. The r value, slope and intercept of this correlation will constitute the primary endpoint of this study. Specifically, we will establish the r value, slope and intercept for: LFOV-Planar vs LFOV-TOMO, LFOV-Planar vs SFOV-HE-TOMO, LFOV-TOMO vs SFOV-HE-TOMO. | 3 months post-enrollment close |
| Measure | Description | Time Frame |
|---|---|---|
| Image Quality | We will investigate differences between the measurements in the SFOV-HE using the forward projections of the tomographic data and tomographic measurements of the H/M as other methods of establishing the correlation between tomographic and planar measurement of mIBG uptake. | 3 month post-enrollment close |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Timothy M Bateman, MD | Aspire Foundation | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cardiovascular Imaging Technologies | Kansas City | Missouri | 64111 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Single Photon Emission Computed Tomography | Other |
|
|
| ID | Term |
|---|---|
| D006333 | Heart Failure |
| D009202 | Cardiomyopathies |
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided